Lataa...
Fractalkine/CX3CL1: A Potential New Target for Inflammatory Diseases
A better understanding of the immunological processes governed by cytokines and chemokines has shaped our approach to the design of therapeutics for diseases such as rheumatoid arthritis (RA), atherosclerosis, and other inflammatory disorders. The discovery of chemokines and their receptors as integ...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Pharmacology and Experimental Therapeutics
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3002219/ https://ncbi.nlm.nih.gov/pubmed/21045240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mi.10.5.3 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|